Logo image of GEHC

GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

NASDAQ:GEHC - Nasdaq - US36266G1076 - Common Stock - Currency: USD

73.11  -0.29 (-0.4%)

After market: 72.97 -0.14 (-0.19%)

Fundamental Rating

5

Overall GEHC gets a fundamental rating of 5 out of 10. We evaluated GEHC against 503 industry peers in the Health Care Equipment & Supplies industry. GEHC scores excellent on profitability, but there are concerns on its financial health. GEHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year GEHC was profitable.
In the past year GEHC had a positive cash flow from operations.
GEHC had positive earnings in each of the past 5 years.
GEHC had a positive operating cash flow in each of the past 5 years.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

GEHC has a better Return On Assets (6.50%) than 87.77% of its industry peers.
GEHC's Return On Equity of 23.76% is amongst the best of the industry. GEHC outperforms 95.74% of its industry peers.
GEHC has a Return On Invested Capital of 8.50%. This is amongst the best in the industry. GEHC outperforms 89.36% of its industry peers.
GEHC had an Average Return On Invested Capital over the past 3 years of 8.36%. This is significantly below the industry average of 13.70%.
The 3 year average ROIC (8.36%) for GEHC is below the current ROIC(8.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.5%
ROE 23.76%
ROIC 8.5%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

GEHC has a better Profit Margin (11.03%) than 86.17% of its industry peers.
In the last couple of years the Profit Margin of GEHC has grown nicely.
GEHC's Operating Margin of 13.71% is amongst the best of the industry. GEHC outperforms 81.91% of its industry peers.
In the last couple of years the Operating Margin of GEHC has remained more or less at the same level.
With a Gross Margin value of 41.99%, GEHC is not doing good in the industry: 64.89% of the companies in the same industry are doing better.
GEHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.71%
PM (TTM) 11.03%
GM 41.99%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

GEHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for GEHC has been increased compared to 1 year ago.
GEHC has a better debt/assets ratio than last year.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

GEHC has an Altman-Z score of 1.83. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
GEHC has a Altman-Z score of 1.83. This is comparable to the rest of the industry: GEHC outperforms 58.51% of its industry peers.
GEHC has a debt to FCF ratio of 6.40. This is a slightly negative value and a sign of low solvency as GEHC would need 6.40 years to pay back of all of its debts.
GEHC's Debt to FCF ratio of 6.40 is fine compared to the rest of the industry. GEHC outperforms 78.72% of its industry peers.
GEHC has a Debt/Equity ratio of 0.74. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
GEHC's Debt to Equity ratio of 0.74 is on the low side compared to the rest of the industry. GEHC is outperformed by 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 6.4
Altman-Z 1.83
ROIC/WACC1.06
WACC8.05%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GEHC has a Current Ratio of 0.98. This is a bad value and indicates that GEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, GEHC is not doing good in the industry: 89.89% of the companies in the same industry are doing better.
A Quick Ratio of 0.76 indicates that GEHC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.76, GEHC is doing worse than 88.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.76
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.29% over the past year.
The Earnings Per Share has been growing slightly by 5.32% on average over the past years.
GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 1.55%.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)15.29%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%12.22%
Revenue 1Y (TTM)1.55%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%2.73%

3.2 Future

GEHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.34% yearly.
The Revenue is expected to grow by 3.52% on average over the next years.
EPS Next Y-7.95%
EPS Next 2Y1.82%
EPS Next 3Y5.67%
EPS Next 5Y5.34%
Revenue Next Year3.04%
Revenue Next 2Y3.87%
Revenue Next 3Y4.14%
Revenue Next 5Y3.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.89, GEHC is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 82.45% of the companies listed in the same industry.
GEHC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.71 indicates a correct valuation of GEHC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 81.91% of the companies listed in the same industry.
GEHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.89
Fwd PE 15.71
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.64% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GEHC is valued cheaper than 84.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.36
EV/EBITDA 12.13
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

GEHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.98
EPS Next 2Y1.82%
EPS Next 3Y5.67%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.20%, GEHC is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.39, GEHC pays a better dividend. On top of this GEHC pays more dividend than 90.43% of the companies listed in the same industry.
With a Dividend Yield of 0.20, GEHC pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

2.61% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP2.61%
EPS Next 2Y1.82%
EPS Next 3Y5.67%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

More info and screens

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (6/12/2025, 8:00:01 PM)

After market: 72.97 -0.14 (-0.19%)

73.11

-0.29 (-0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners88.13%
Inst Owner Change-1.49%
Ins Owners0.18%
Ins Owner Change0.43%
Market Cap33.48B
Analysts80.77
Price Target88.89 (21.58%)
Short Float %1.49%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.61%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-25 2025-04-25 (0.035)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.46%
Min EPS beat(2)8.42%
Max EPS beat(2)12.49%
EPS beat(4)4
Avg EPS beat(4)6.81%
Min EPS beat(4)0.18%
Max EPS beat(4)12.49%
EPS beat(8)7
Avg EPS beat(8)5.57%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-2.17%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.79%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-13.02%
EPS NQ rev (1m)-1.1%
EPS NQ rev (3m)-15.78%
EPS NY rev (1m)-13.66%
EPS NY rev (3m)-13.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.5%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 15.89
Fwd PE 15.71
P/S 1.69
P/FCF 24.36
P/OCF 18.79
P/B 3.64
P/tB N/A
EV/EBITDA 12.13
EPS(TTM)4.6
EY6.29%
EPS(NY)4.65
Fwd EY6.37%
FCF(TTM)3
FCFY4.1%
OCF(TTM)3.89
OCFY5.32%
SpS43.24
BVpS20.06
TBVpS-11.85
PEG (NY)N/A
PEG (5Y)2.98
Profitability
Industry RankSector Rank
ROA 6.5%
ROE 23.76%
ROCE 11.49%
ROIC 8.5%
ROICexc 9.49%
ROICexgc 30.64%
OM 13.71%
PM (TTM) 11.03%
GM 41.99%
FCFM 6.94%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexcg growth 3Y-14.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 6.4
Debt/EBITDA 2.07
Cap/Depr 71.83%
Cap/Sales 2.06%
Interest Coverage 4.74
Cash Conversion 54.3%
Profit Quality 62.94%
Current Ratio 0.98
Quick Ratio 0.76
Altman-Z 1.83
F-Score5
WACC8.05%
ROIC/WACC1.06
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)15.29%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%12.22%
EPS Next Y-7.95%
EPS Next 2Y1.82%
EPS Next 3Y5.67%
EPS Next 5Y5.34%
Revenue 1Y (TTM)1.55%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%2.73%
Revenue Next Year3.04%
Revenue Next 2Y3.87%
Revenue Next 3Y4.14%
Revenue Next 5Y3.52%
EBIT growth 1Y12.33%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year11.86%
EBIT Next 3Y9.57%
EBIT Next 5Y8.87%
FCF growth 1Y-9.57%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-7.14%
OCF growth 3Y6.68%
OCF growth 5Y1.2%